GS 840 oral prodrug of GS 393 nucleotide analog: Began Phase I testing in infected patients

Gilead Sciences Inc.

Read the full 30 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE